Editorial: The Evolving Landscape, Clinical Implications, and Future Perspective of Biomarkers in Gastrointestinal Cancers

Front Oncol. 2022 May 3:12:895231. doi: 10.3389/fonc.2022.895231. eCollection 2022.

Hsiang-Lin Tsai^{1

2}, Yen-Cheng Chen^{1

3}, Kenneth Kw To⁴, Jaw-Yuan Wang^{1

2

3

5

6

7

8}

¹ Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
² Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
³ Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
⁴ School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
⁵ Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
⁶ Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
⁷ Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
⁸ Pingtung Hospital, Ministry of Health and Welfare, Pingtung, Taiwan.

No abstract available

Keywords: biomarkers; early detection; evolving landscape; gastrointestinal cancers; postoperative surveillance.

Publication types